AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
132.86B
FCIWX
Price
$17.24
Change
+$0.05 (+0.29%)
Updated
Sep 4 closing price
Net Assets
770.26M
Interact to see
Advertisement

AEPCX vs FCIWX

Header iconAEPCX vs FCIWX Comparison
Open Charts AEPCX vs FCIWXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets132.86B
NYLI PineStone International Eq Cl R6
Price$17.24
Change+$0.05 (+0.29%)
VolumeN/A
Net Assets770.26M
AEPCX vs FCIWX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FCIWX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and FCIWX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FCIWX (770M). FCIWX pays higher dividends than AEPCX: FCIWX (0.64) vs AEPCX (0.16). AEPCX was incepted earlier than FCIWX: AEPCX (25 years) vs FCIWX (8 years). AEPCX (1.57) is less costly to investors than FCIWX (0.89). AEPCX is a more actively managed with annual turnover of: 35.00 vs. FCIWX (10.00). FCIWX has a lower initial minimum investment than AEPCX: FCIWX (0) vs AEPCX (250). AEPCX annual gain was more profitable for investors over the last year : 7.59 vs. FCIWX (0.30). FCIWX return over 5 years is better than : 39.92 vs. AEPCX (7.78).
AEPCXFCIWXAEPCX / FCIWX
Total Expense Ratio1.570.80196%
Annual Report Gross Expense Ratio1.570.89176%
Fund Existence25 years8 years-
Gain YTD15.0385.832258%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B770M17,273%
Annual Yield % from dividends0.160.6425%
Returns for 1 year7.590.302,518%
Returns for 3 years32.6543.4275%
Returns for 5 years7.7839.9219%
Returns for 10 years34.34N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.